MA10-MA50 Bull Crossover: Alkermes Plc (ALKS), Hologic Inc (HOLX), Neurocrine Bioscience (NBIX), Sangamo Biosciences (SGMO)

NASDAQ: ALKS (Alkermes Plc)

NASDAQ: ALKS (Alkermes Plc) has closed at $36.35, its traded Volume was 1356.95K shares, ALKS opened the Day at $35.65, it made an intraday Low of $35.58, and an intraday High of $37.36. ALKS (Alkermes Plc) 52-week High is $80.71, 52-week Low is: $27.14, it has supports at $31.16 and $27.13, resistances at $37.7 and $44.03. ALKS’s earning is $-1.52 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -24. Overall, this stock is rated BUY today.

NASDAQ: HOLX (Hologic Inc)

NASDAQ: HOLX (Hologic Inc) has closed at $35.21, its traded Volume was 3223.22K shares, HOLX opened the Day at $34.69, it made an intraday Low of $34.52, and an intraday High of $35.45. HOLX (Hologic Inc) 52-week High is $43, 52-week Low is: $31.84, it has supports at $33.65 and $31.84, resistances at $36.58 and $42.72. HOLX’s earning is $0.64 per share, Next quarter estimated EPS is $0, current year estimated EPS is $3.84. Its PE ratio is 55. Overall, this stock is rated BUY today.

NASDAQ: NBIX (Neurocrine Bioscienc)

NASDAQ: NBIX (Neurocrine Bioscienc) has closed at $42.93, its traded Volume was 1865.84K shares, NBIX opened the Day at $42, it made an intraday Low of $42, and an intraday High of $44.48. NBIX (Neurocrine Bioscienc) 52-week High is $58.46, 52-week Low is: $31.25, it has supports at $39.81 and $31.25, resistances at $53.68 and $62.69. NBIX’s earning is $-1.05 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -41. Overall, this stock is rated BUY today.

NASDAQ: SGMO (Sangamo Biosciences)

NASDAQ: SGMO (Sangamo Biosciences) has closed at $6.31, its traded Volume was 1105.44K shares, SGMO opened the Day at $6.31, it made an intraday Low of $6.24, and an intraday High of $6.65. SGMO (Sangamo Biosciences) 52-week High is $16.1, 52-week Low is: $4.63, it has supports at $5.52 and $4.63, resistances at $6.96 and $8.12. SGMO’s earning is $-0.58 per share, Next quarter estimated EPS is $0, current year estimated EPS is $5.85. Its PE ratio is -11. Overall, this stock is rated BUY today.